Singular Genomics Systems, Inc. (OMIC) has 12 open-market insider trades by 6 insiders since 2021. The most active filer is Andrew Spaventa, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James E. Flynn | 10% | — | 1 | $33.0M | 2021-06-01 |
| TANG Capital Management LLC | 10% | — | 1 | $1.8M | 2024-09-18 |
| Kim P. Kamdar | Dir | — | 1 | $575K | 2025-02-21 |
| Eli N. Glezer | CSO | — | 3 | $325K | 2025-02-21 |
| Michael J. Pellini | Dir | — | 1 | $177K | 2025-02-21 |
| Andrew Spaventa | CEO | — | 5 | $87K | 2025-02-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrew Spaventa | CEO | Sell | $16K | 2025-02-14 |
| Andrew Spaventa | CEO | Sell | $4K | 2024-12-16 |
| Andrew Spaventa | CEO | Sell | $16K | 2024-11-12 |
| TANG Capital Management LLC | 10% | Buy | $1.8M | 2024-09-16 |
| Andrew Spaventa | CEO | Sell | $2K | 2024-09-15 |
| Andrew Spaventa | CEO | Buy | $49K | 2023-11-16 |
Companies that share insiders with OMIC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Eli N. Glezer | CSO | Buy | $86K | 2023-11-16 |
| Kim P. Kamdar | Director | Sell | $575K | 2023-08-11 |
| Eli N. Glezer | CSO | Buy | $139K | 2023-05-17 |
| Eli N. Glezer | CSO | Buy | $100K | 2022-12-12 |
| Michael J. Pellini | Director | Buy | $177K | 2022-05-18 |
| James E. Flynn | 10% | Buy | $33.0M | 2021-06-01 |